Canadian Respiratory Journal

Canadian Respiratory Journal / 2014 / Article

Clinico-Pathologic Conferences | Open Access

Volume 21 |Article ID 914719 | https://doi.org/10.1155/2014/914719

Natasha Satkunam, Zaeem A Siddiqi, Dilini Vethanayagam, "Severe Asthma Associated with Myasthenia Gravis", Canadian Respiratory Journal, vol. 21, Article ID 914719, 3 pages, 2014. https://doi.org/10.1155/2014/914719

Severe Asthma Associated with Myasthenia Gravis

Abstract

Severe asthma constitutes a subgroup of approximately 10% of all asthma cases. Approximately one-half of these individuals have a refractory form of the disease in which atopy and T-helper cell 2-skewed immunological response may not be as closely linked to the disease as in other phenotypes of asthma. This suggests that not all asthma is explained by a T-helper cell 2-skewed immunological response, and that other immunological mechanisms may be important in this category of nonatopic asthma. The authors present a case involving a 55-year-old Caucasian man with nonatopic, adult-onset asthma, nonsteroidal anti-inflammatory drug sensitivity and idiopathic urticaria. This individual presented two years following his initial asthma diagnosis with diplopia and mild ptosis, and was subsequently diagnosed with seropositive myasthenia gravis.

Copyright © 2014 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views418
Downloads281
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.